scholarly journals Adenosine kinase deficiency with neurodevelopemental delay and recurrent hepatic dysfunction: A case report

2016 ◽  
Keyword(s):  
Case Report ◽  
Hepatic Dysfunction ◽  
Adenosine Kinase

Adenosine kinase deficiency with neurodevelopemental delay and recurrent hepatic dysfunction: A case report

2016 ◽  
Vol 03 (01) ◽  
Author(s):  
Shakiba M ◽  
Mahjoub F ◽  
Fazilaty H ◽  
Rezagholizadeh F ◽  
Shakiba A ◽  
...  
Keyword(s):  
Case Report ◽  
Hepatic Dysfunction ◽  
Adenosine Kinase

Hepatic dysfunction in two sibs with Alström syndrome: Case report and review of the literature

1997 ◽  
Vol 69 (1) ◽  
pp. 13-16 ◽  
Author(s):  
Midori Awazu ◽  
Tetsuya Tanaka ◽  
Seiji Sato ◽  
Makoto Anzo ◽  
Masataka Higuchi ◽  
...  
Keyword(s):  
Case Report ◽  
Hepatic Dysfunction ◽  
Review Of The Literature ◽  
Alström Syndrome ◽  
Alstrom Syndrome

scholarly journals A SINGLE CASE REPORT ON HYPERAMMONEMIA INDUCED BY VALPROATE MONOTHERAPY WITHOUT HEPATIC DYSFUNCTION

2017 ◽  
Vol 9 (4) ◽  
pp. 218 ◽  
Author(s):  
C. Prarthana Saraswathi ◽  
J. Anu Rita ◽  
S. Nambi
Keyword(s):  
Case Report ◽  
Mental Status ◽  
Hepatic Dysfunction ◽  
Single Case ◽  
Bipolar Affective Disorder ◽  
Mood Stabilizer ◽  
Altered Mental Status ◽  
Plasma Ammonia ◽  
Manic Symptoms ◽  
Single Case Report

Valproate is a commonly used mood stabilizer. One of the important and rare side effects of valproate is hyperammonemia leading to delirium and hepatic encephalopathy. Valproate-induced delirium is commonly mistaken for worsening of manic symptoms or psychosis. We hereby report a case of bipolar affective disorder who was on a therapeutic dose of valproate monotherapy developed altered mental status where we found elevated levels of plasma ammonia which decreased after the discontinuation of valproate and with normal levels of serum valproate, LFT’s, EEG and imagings. This case report emphasises on the need to consider plasma ammonia levels in patients with altered mental status receiving valproate in addition to other investigations.

A Case of Postoperative Acute Hepatic Dysfunction after Sevoflurane Anesthesia: A case report

2006 ◽  
Vol 51 (3) ◽  
pp. 359 ◽  
Author(s):  
Yong Son ◽  
Yong Kwan Cheong ◽  
Dea Jung Kim
Keyword(s):  
Case Report ◽  
Hepatic Dysfunction ◽  
Sevoflurane Anesthesia

Liver Injury After Oral and Rectal Administration of N-Acetylcysteine for Meconium Ileus Equivalent in a Patient With Cystic Fibrosis

PEDIATRICS ◽  
1987 ◽  
Vol 79 (2) ◽  
pp. 281-282
Author(s):  
DAVID J. BAILEY ◽  
JOEL M. ANDRES
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Adverse Reactions ◽  
Hepatic Dysfunction ◽  
Pancreatic Enzyme ◽  
Rectal Administration ◽  
Meconium Ileus ◽  
Left Femur ◽  
Enzyme Replacement ◽  
Mucolytic Agent

N-acetylcysteine (NAC) is a mucolytic agent (Mucomyst, Mead-Johnson) that is often used for the treatment of meconium ileus equivalent, a complication of cystic fibrosis.1-3 No serious adverse reactions to nonparenterally administered NAC have been observed, and there have been no reports of significant hepatotoxicity. We describe a patient in whom severe hepatic dysfunction occurred on two occasions after the administration of NAC for the treatment of meconium ileus equivalent. CASE REPORT A 3-year-old, 12.5-kg, white boy with cystic fibrosis was admitted for treatment of a fractured left femur. His medications included theophylline, metaproterenol, cefaclor, nebulized isoethanine, and pancreatic enzyme replacement with meals.

Delayed Recovery after Continuous Infusion of Midazolam in Hepatic Dysfunction: A case report

2006 ◽  
Vol 51 (3) ◽  
pp. 363
Author(s):  
Hyo Seok Kang ◽  
Jong Oh Lim ◽  
So Jin Park ◽  
Soo Kyeong Choi ◽  
Hae Jin Park ◽  
...  
Keyword(s):  
Case Report ◽  
Continuous Infusion ◽  
Hepatic Dysfunction ◽  
Delayed Recovery
Sign in / Sign up

Export Citation Format

Share Document